SCHEMBL24840552

SCHEMBL24840552

OC[C@H]1O[C@@]2(CCCNC2)[C@H](O)[C@@H](n2cc(-c3cc(F)c(F)c(F)c3)nn2)[C@H]1O

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 20/20 0.55
▸ LGALS1 P09382 4/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24840533 1.00 LGALS3 (0.55) LGALS3LGALS1
SCHEMBL27212420 1.00 LGALS3 (0.55) LGALS3LGALS1
SCHEMBL30901860 1.00 LGALS3 (0.55) LGALS3LGALS1
SCHEMBL24840618 0.90 LGALS3 (0.61) LGALS3LGALS1
SCHEMBL24840575 0.81 LGALS3 (0.57) LGALS3LGALS1
SCHEMBL24841186 0.80 LGALS3 (0.56) LGALS3LGALS1
SCHEMBL27212411 0.80 LGALS3 (0.56) LGALS3LGALS1
SCHEMBL24840647 0.80 LGALS3 (0.58) LGALS3LGALS1
SCHEMBL24841018 0.80 LGALS3 (0.58) LGALS3LGALS1
SCHEMBL24840580 0.80 LGALS3 (0.58) LGALS3LGALS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117836306-A Galactose glycoside derivatives as galectin-3 inhibitors 株式会社蒂奥姆生物 2024-04-05 — — CN claimed
WO-2023277630-A1 GALACTOSIDE DERIVATIVE AS GALECTIN-3 INHIBITOR 주식회사 티움바이오 2023-01-05 — — WO claimed
EP-4365181-A1 GALACTOSIDE DERIVATIVE AS GALECTIN-3 INHIBITOR TiumBio Co., Ltd. (KR) 2024-05-08 — — EP disclosed
CN-117836306-A Galactose glycoside derivatives as galectin-3 inhibitors 株式会社蒂奥姆生物 2024-04-05 — — CN disclosed
WO-2023277630-A1 GALACTOSIDE DERIVATIVE AS GALECTIN-3 INHIBITOR 주식회사 티움바이오 2023-01-05 — — WO disclosed
WO-2023277630-A1 GALACTOSIDE DERIVATIVE AS GALECTIN-3 INHIBITOR 주식회사 티움바이오 2023-01-05 — — WO disclosed
Send feedback